We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+15.92%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
10 Year Est. Return
AUM
$158M
AUM Growth
+$11.6M
Cap. Flow
+$75.4M
Cap. Flow %
47.55%
Top 10 Hldgs %
13.24%
Holding
160
New
59
Increased
17
Reduced
24
Closed
60

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.02M
2
DVN icon
Devon Energy
DVN
+$1.79M
3
CRM icon
Salesforce
CRM
+$1.74M
4
PANW icon
Palo Alto Networks
PANW
+$1.72M
5
META icon
Meta Platforms (Facebook)
META
+$1.69M

Sector Composition

Rank Sector Weight
1 Technology 50.88%
2 Consumer Discretionary 20.42%
3 Healthcare 7.72%
4 Industrials 6.9%
5 Consumer Staples 3.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACI icon
51
Albertsons Companies
ACI
$5.95B
$1.56M 0.99%
+51,790
New +$1.64M
SMTC icon
52
Semtech
SMTC
$12.2B
$1.56M 0.99%
17,557
-825
-4% -$70.2K
SNA icon
53
Snap-on
SNA
$21.4B
$1.56M 0.99%
+7,251
New +$1.55M
NVT icon
54
nVent Electric
NVT
$26.9B
$1.56M 0.98%
41,010
-4,647
-10% -$165K
MSP
55
DELISTED
Datto Holding Corp.
MSP
$1.55M 0.98%
+58,875
New +$1.43M
BPMC
56
DELISTED
Blueprint Medicines
BPMC
$1.55M 0.98%
+14,459
New +$1.51M
CFLT
57
DELISTED
Confluent
CFLT
$1.55M 0.98%
+20,299
New +$1.46M
LAD icon
58
Lithia Motors
LAD
$8.4B
$1.55M 0.98%
+5,211
New +$1.61M
ONTO icon
59
Onto Innovation
ONTO
$15.4B
$1.54M 0.97%
15,249
-4,063
-21% -$351K
P
60
Everpure Inc
P
$35.6B
$1.54M 0.97%
47,326
-8,439
-15% -$245K
IONS icon
61
Ionis Pharmaceuticals
IONS
$9.24B
$1.54M 0.97%
+50,614
New +$1.59M
AOSL icon
62
Alpha and Omega Semiconductor
AOSL
$1.04B
$1.54M 0.97%
25,374
-18,503
-42% -$801K
AMBA icon
63
Ambarella
AMBA
$3.62B
$1.53M 0.97%
7,556
-1,301
-15% -$241K
IAA
64
DELISTED
IAA, Inc. Common Stock
IAA
$1.53M 0.96%
+30,195
New +$1.61M
SHOO icon
65
Steven Madden
SHOO
$3.54B
$1.52M 0.96%
+32,839
New +$1.51M
UCTT
66
Ultra Clean Holdings
UCTT
$3.83B
$1.52M 0.96%
+26,478
New +$1.38M
CCRN
67
DELISTED
Cross Country Healthcare
CCRN
$1.51M 0.96%
54,580
-13,223
-20% -$321K
EVRI
68
DELISTED
Everi Holdings
EVRI
$1.51M 0.95%
+70,907
New +$1.62M
LSCC icon
69
Lattice Semiconductor
LSCC
$17.8B
$1.51M 0.95%
19,648
-2,675
-12% -$199K
SKY icon
70
Champion Homes
SKY
$5.13B
$1.51M 0.95%
+19,162
New +$1.38M
DIOD icon
71
Diodes
DIOD
$4.71B
$1.51M 0.95%
+13,763
New +$1.4M
URBN icon
72
Urban Outfitters
URBN
$6.8B
$1.51M 0.95%
51,347
+5,763
+13% +$183K
BOOT icon
73
Boot Barn
BOOT
$5.09B
$1.5M 0.94%
12,179
-2,865
-19% -$324K
BOX icon
74
Box
BOX
$4.57B
$1.5M 0.94%
+57,162
New +$1.47M
KSS icon
75
Kohl's
KSS
$2.1B
$1.5M 0.94%
+30,311
New +$1.55M

Similar funds

Alpha DNA Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, Alpha DNA Investment Management held 160 positions worth $158M, up 7.9% from $147M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Alpha DNA Investment Management deployed $75.4M of net new capital in Q4 2021, opening 59 new positions and adding to 17 existing holdings. Its largest new stake was CrowdStrike: 36,316 shares worth $1.86M.

By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $2.02M trimmed.

  • Alpha DNA Investment Management's largest Q4 2021 buy was CrowdStrike: 36,316 shares worth $1.86M.
  • Alpha DNA Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $19.3M increase.
  • Alpha DNA Investment Management's biggest Q4 2021 reduction was Apple, cutting an estimated $2.02M.
  • Alpha DNA Investment Management fully exited Devon Energy in Q4 2021, selling an estimated $1.79M.
  • Alpha DNA Investment Management's ten largest holdings make up 13% of its $158M portfolio in Q4 2021.
  • Alpha DNA Investment Management opened 59 new positions and closed 60 in Q4 2021.
  • Alpha DNA Investment Management's portfolio value rose 7.9% quarter-over-quarter to $158M.

Based on Alpha DNA Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.